Site Map

Privacy Policy | Liability Statement


ICCBBA, Inc.

ICCBBA enhances safety for patients by managing and promoting the ISBT 128 international information standard for use in transfusion and transplantation.

©2017 ICCBBA. All Rights Reserved.


Published Papers

This section contains citations for scientific papers and articles that feature information about ISBT 128.

Blood

Cellular Therapy

Medical Devices

Ocular

Tissue

Newsletters

Graphic Publications

 

Blood Transfusion Publications

  • Ashford, P. ISBT 128: contributing to the safety of transfusion and transplantation. ISBT 128 Science Series (2007) 2:113-116.
  • Ashford P. Fearon M., Bedford R.  Report on the joint IBEPAG/ICCBBA survey on import/export and blood component labeling. Vox Sang (2010) 98, 85–86.  
  • Ashford, P. Gullikson J, Georgsen, J and Distler, P.  Standard terminology for platelet additive solutions.  Vox Sang (2010) 98(4):577-578.
  • Ashford P.  ISBT 128 – Improving Security by International Standardization. ISBT Science Series (1) 242-245 (2006).
  • Butch, SH. and Distler, PB. ISBT 128 blood labeling: introduction and reference laboratory applications. Immunohematology (2006): 22:30-35.
  • Distler, PB. ISBT 128 An internationally standardized means to label cellular therapy products. Pharmaceuticals Policy and Law (2007) 9:421-430.
  • Munk, Charles et al., ISBT 128: The Implementation Project of the Swiss Red Cross Blood Transfusion Service. ISBT Congress Proceeding, Journal of Blood Banks, and Transfusion Society of Turkey, July (2003).
  • Guidelines for the use of RFID technology in transfusion medicine. Vox Sang (2010) 98:1-24. (Special Issue)
  • EBA Board adopts Position Paper on the labelling, coding and identification of blood, blood components, tissues and cells
    At the Board Meeting in Valletta, Malta, the EBA Board has voted to support the universal use of the ISBT 128 for labelling, coding and identification of blood, blood components, tissues and cells.

EBA Position Paper on Coding and Labeling – PDF (01 Oct 2010)

 

[Top ↑]

Cellular Therapy Publications

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products: 1. Standards. Bone marrow transplantation 2007;40(11):1075-83.
  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products 2: Implementation plan. Bone marrow transplantation 2007;40(11):1085-90.
  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products.Transfusion 2007;47(7):1319-27.

    http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2007.01389.x/pdf

     
    You must be a registered member with AABB to access this publication.
  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Transfusion 2007;47(7):1312-8.

    http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2007.01390.x/pdf

     
    You must be a registered member with AABB to access this publication.
  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Journal of clinical apheresis 2007;22(5):258-64.
  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products. Journal of clinical apheresis 2007;22(5):249-57.

 

[Top ↑]

Medical Device Publications

  • Conway, Karen. The Human Side of UDI. Healthcare Purchasing News. Healthcare Purchasing News, July 2016.

 

[Top ↑]

Ocular Publications

  • Armitage, W. John; Ashford, Paul; Crow, Barbara; Dahl, Patricia; DeMatteo, Jennifer; Distler, Pat; Gopinathan, Usha; Madden, Peter W.; Mannis, Mark J.; Moffatt, S. Louise; Ponzin, Diego; Tan, Donald. Standard Terminology and Labeling of Ocular Tissue for Transplantation.Cornea32(6):725-728, June 2013. doi: 10.1097/ICO.0b013e3182873405.
    Standard Terminology and Labeling of Ocular Tissue for Transplantation

 

  • W. John Armitage, PhD; Paul Ashford, MSc; Barbara Crow; Patricia Dahl; Pat Distler, MS; Jennifer DeMatteo, MCM, CIC; Usha Gopinathan, PhD; Mark Mannis, MD; S. Louise Moffatt, BSc; Christina Parsons; Diego Ponzin, MD; Donald Tan, MD. Implementation of Standardized Terminology and ISBT 128 Product Codes for Ocular Tissue. International Journal of Eye Banking vol. 2 no. 1, March 2014. doi:10.7706/ijeb.v2i1.64.
    Implementation of Standardized Terminology and ISBT 128 Product Codes for Ocular Tissue

 

[Top ↑]

Tissue Publications

  • Ashford, P. Traceability. Cell and Tissue Banking (2010). Published online 14 July 2010.
  • Fehily, D., Ashford, P., Poniatowski, S. Traceability of Human Tissues for Transplantation – the development and implementation of a coding system using ISBT 128. Organs and Tissues (2004) (2) 83-88.

 

[Top ↑]

Newsletters

 

Graphic Publications

 

 

[Back to Top ↑]